Authors
Orlaith O'Reilly
Office of the National Clinical Advisor and Programme Group Lead for Chronic Disease, Clinical Design & Innovation, Office of the Chief Clinical Officer, HSE – South (SE), Ireland
Sarah O'Brien
Office of the National Clinical Advisor and Programme Group Lead for Chronic Disease, Clinical Design & Innovation, Office of the Chief Clinical Officer, HSE – South (SE), Ireland
Margaret Humphreys
Office of the National Clinical Advisor and Programme Group Lead for Chronic Disease, Clinical Design & Innovation, Office of the Chief Clinical Officer, HSE – South (SE), Ireland
Mairead Gleeson
Office of the National Clinical Advisor and Programme Group Lead for Chronic Disease, Clinical Design & Innovation, Office of the Chief Clinical Officer, HSE – South (SE), Ireland
Susan Connolly
Western Health and Social Care Trust, National Health Service, United Kingdom
Celia O'Hare
Office of the National Clinical Advisor and Programme Group Lead for Chronic Disease, Clinical Design & Innovation, Office of the Chief Clinical Officer, HSE – South (SE), Ireland
Susan Curtis
Office of the National Clinical Advisor and Programme Group Lead for Chronic Disease, Clinical Design & Innovation, Office of the Chief Clinical Officer, HSE – South (SE), Ireland
Desmond Murphy
Office of the National Clinical Advisor and Programme Group Lead for Chronic Disease, Clinical Design & Innovation, Office of the Chief Clinical Officer, HSE – South (SE), Ireland
Cork University Hospital, Ireland